iShares Biotechnology ETF
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has iShares Biotechnology ETF's balance sheet done over the years? Its assets were worth $1,822,401,190 last year. 11% of iShares Biotechnology ETF’s total assets is currently financed by debt. Its liabilities reached the amount of $208,310,460.
Debt to Assets
| 2010 | 1822401190 | 208.31M | 11.43% |
|---|
IBB Balance Sheet (2010 – 2010)
| 2010 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 0 |
Short term investments | 0 |
Net receivables | 2.82M |
Inventory | 0 |
Other current assets | 0 |
Total current assets | 0 |
Non-current assets: | |
Property, Plant and Equipment | 0 |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 1.81B |
Other non-current assets | 0 |
Total non-current assets | 0 |
Total assets | 1.82B |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 0 |
Total current liabilities | 0 |
| Non-current liabilities: | |
Long term debt | 0 |
Deferred tax | 0 |
Other non-current liabilities | 0 |
Total non-current liabilities | 0 |
Total liabilities | 208.31M |